"10.1371_journal.pone.0113936","plos one","2014-12-01T00:00:00Z","Sara Llufriu; María Sepúlveda; Yolanda Blanco; Pedro Marín; Beatriz Moreno; Joan Berenguer; Iñigo Gabilondo; Eloy Martínez-Heras; Nuria Sola-Valls; Joan-Albert Arnaiz; Enrique J Andreu; Begoña Fernández; Santi Bullich; Bernardo Sánchez-Dalmau; Francesc Graus; Pablo Villoslada; Albert Saiz","Center of Neuroimmunology, Service of Neurology, Hospital Clinic and Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain; Hemotherapy Service, CDB, Hospital Clínic, Barcelona, Spain; Service of Neurorradiology, Hospital Clinic and Institut d′Investigació Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain; Department of Clinical Pharmacology, Hospital Clinic, Barcelona, Spain; Cell Therapy Area, Clinica Universitaria de Navarra, Pamplona, Spain; Service of Ophtalmology, Hospital Clinic, Barcelona, Spain","Conceived and designed the experiments: SL MS YB PM BM JB IG EMH NSV JAA BF SB BSD FG PV AS. Performed the experiments: SL MS YB BM JB IG EMH NSV EJA BF SB BSD PV AS. Analyzed the data: SL MS YB BM IG EMH NSV EJA BF SB FG PV AS. Contributed reagents/materials/analysis tools: SL MS YB PM BM JB IG EMH NSV JAA EJA BF SB BSD. Wrote the paper: SL MS YB PM BM JB IG EMH NSV JAA EJA BF SB BSD FG PV AS.","SL, MS, YB, PM, BM, JB, IG, EMH, NSV, JAA, JA, BF, SB, BSD and FG have nothing to declare. PV has received consultancy fees from Novartis, Roche, Neurotek, Heidelberg Engineering, Digna Biotech, Bionure and TFS and research grants from Novartis, Roche and Digna Biotech, and is founder and holds stocks in Bionure. AS has received compensation for consulting services and speaking from Bayer-Schering, Merck-Serono, Biogen-Idec, Sanofi-Aventis, Teva Pharmaceutical Industries Ltd and Novartis. Dr. Pablo Villoslada, co-author of the paper, is a PLOS ONE Editorial Board member. This does not alter the authors adherence to PLOS ONE Editorial policies and criteria.","2014","12","Sara Llufriu","SL",17,TRUE,16,14,13,17,TRUE,TRUE,FALSE,0,NA,FALSE
